Effects of moderate red wine consumption on liver fat and blood lipids: A prospective randomized study

Annals of Medicine

Volumn 43, Issue 7, 2011, Pages 545-554

  Kechagias, Stergios ^a   Zanjani, Sepehr ^a   Gjellan, Solveig ^a   Leinhard, Olof Dahlqvist ^a   Kihlberg, Johan ^a   Smedby, Örjan ^a   Johansson, Lars ^b   Kullberg, Joel ^b   Ahlström, Hkan ^b   Lindström, Torbjörn ^a   Nystrom, Fredrik H ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alcohol; Hepatic triglyceride content; NAFLD

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RED WINE;

ADULT; ALCOHOL DRINKING; CHOLESTEROL, LDL; ETHANOL; FATTY LIVER; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSPECTIVE STUDIES; TRIGLYCERIDES; WINE;

EID: 80053104348     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2011.588246     Document Type: Article

References (46)

1. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000;95:1505-23.
2. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005;51:931-8. (Pubitemid 40740871)
3. Gottrand F, Beghin L, Duhal N, Lacroix B, Bonte JP, Fruchart JC, et al. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII. Eur J Clin Invest. 1999;29:387-94. (Pubitemid 29209760)
4. Naissides M, Mamo JC, James AP, Pal S. The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. Atherosclerosis. 2006;185:438-45.
5. Napoli R, Cozzolino D, Guardasole V, Angelini V, Zarra E, Matarazzo M, et al. Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. Metabolism. 2005;54:306-13. (Pubitemid 40250090)
6. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462-8. (Pubitemid 40110657)
7. Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, et al. Review article: alcoholic liver disease - pathophysiological aspects and risk factors. Aliment Pharmacol Ther. 2006;24:1151-61. (Pubitemid 44427503)
8. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434-8. (Pubitemid 10057164)
9. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917-23. (Pubitemid 36397405)
10. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42:44-52. (Pubitemid 40911310)
11. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-95. (Pubitemid 39657013)
12. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865-73. (Pubitemid 46489550)
13. Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut. 2004;53:750-5. (Pubitemid 38561456)
14. Garcia-Monzon C, Martin-Perez E, Iacono OL, Fernandez-Bermejo M, Majano PL, Apolinario A, et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol. 2000;33: 716-24.
15. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53: 372-84.
16. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99-S112.
17. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identifi cation Test. Arch Intern Med. 1998;158:1789-95. (Pubitemid 28421422)
18. Kechagias S, Ernersson A, Dahlqvist O, Lundberg P, Lindstrom T, Nystrom FH. Fast-food-based hyperalimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut. 2008;57:649-54. (Pubitemid 351579979)
19. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001;12:141-52. (Pubitemid 32510133)
20. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and effi cient quantifi cation of MRS data with use of prior knowledge. J Magn Reson. 1997; 129:35-43. (Pubitemid 127454051)
21. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63. (Pubitemid 30022895)
22. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-10. (Pubitemid 32269192)
23. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996;23:1025-9. (Pubitemid 26137041)
24. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut. 1997;41:845-50.
25. Norton R, Batey R, Dwyer T, MacMahon S. Alcohol consumption and the risk of alcohol related cirrhosis in women. Br Med J (Clin Res Ed). 1987;295:80-2. (Pubitemid 17096078)
26. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123: 745-50. (Pubitemid 34977081)
27. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW, Jr., et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997;337:1705-14. (Pubitemid 27527766)
28. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112-17. (Pubitemid 30044177)
29. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48:792-8.
30. Retterstol L, Berge KE, Braaten O, Eikvar L, Pedersen TR, Sandvik L. A daily glass of red wine: does it affect markers of infl ammation? Alcohol Alcohol. 2005;40:102-5. (Pubitemid 40347336)
31. Alatalo P, Koivisto H, Puukka K, Hietala J, Anttila P, Bloigu R, et al. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol. 2009;44: 199-203.
32. Tyulina OV, Prokopieva VD, Boldyrev AA, Johnson P Erythrocyte and plasma protein modifi cation in alcoholism: a possible role of acetaldehyde. Biochim Biophys Acta. 2006;1762:558-63.
33. Ohtake H, Kato S, Murawaki Y, Kishimoto Y, Wakushima T, Hirayama C. Acute and chronic effect of ethanol on hepatic albumin synthesis in rat liver in vitro. Res Commun Chem Pathol Pharmacol. 1986;53:213-31. (Pubitemid 16054542)
34. Rothschild MA, Oratz M, Schreiber SS Serum albumin. Hepatology. 1988;8:385-401.
35. Schapiro RH, Scheig RL, Drummey GD, Mendelson JH, Isselbacher KJ. Effect of prolonged ethanol ingestion on the transport and metabolism of lipids in man. N Engl J Med. 1965;272:610-5.
36. Belfrage P, Berg B, Cronholm T, Elmqvist D, Hagerstrand I, Johansson B, et al. Prolonged administration of ethanol to young, healthy volunteers: effects on biochemical, morphological and neurophysiological parameters. Acta Med Scand Suppl. 1973;552:1-44.
37. Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology. 2009;50:1105-12.
38. Kawano Y. Physio-pathological effects of alcohol on the cardiovascular system: its role in hypertension and cardiovascular disease. Hypertens Res. 2010;33:181-91.
39. Rouleau J. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial. Am J Med. 2005; 118 Suppl 12A:28-35.
40. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
41. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, et al. Effects of long-term fenofi brate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366:1849-61.
42. Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, et al. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med. 2007;356:1620-30. (Pubitemid 46631671)
43. Lof M, Forsum E. Validation of energy intake by dietary recall against different methods to assess energy expenditure. J Hum Nutr Diet. 2004;17:471-80. (Pubitemid 39307102)
44. Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr. 1995;61: 1360S-1367S.
45. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359: 229-41. (Pubitemid 352008438)
46. Marfella R, Cacciapuoti F, Siniscalchi M, Sasso FC, Marchese F, Cinone F, et al. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus. Diabet Med. 2006;23:974-81. (Pubitemid 44257941)